You have 9 free searches left this month | for more free features.

[18-F]-FCH

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Brain Metastases Trial in New York (18F-FCH PET Scan)

Completed
  • Brain Metastases
  • 18F-FCH PET Scan
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 15, 2022

18F-fluorocholine, Positron-Emission Tomography, Hyperparathyroidism, Primary Trial in Toronto ([F-18]-FCH PET/MRI)

Active, not recruiting
  • 18F-fluorocholine
  • +2 more
  • [F-18]-FCH PET/MRI
  • Toronto, Ont, Canada
    UHN
Dec 9, 2022

Hepatocellular Carcinoma Non-resectable Trial in Honolulu (Fluorine-18 fluorocholine)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Fluorine-18 fluorocholine
  • Honolulu, Hawaii
    The Queen's Medical Center
Mar 28, 2022

Myeloma Multiple Trial in Pessac (Positron Emission Tomography using 18F-FCH, Positron Emission Tomography using 18F-FDG)

Recruiting
  • Myeloma Multiple
  • Positron Emission Tomography using 18F-FCH
  • Positron Emission Tomography using 18F-FDG
  • Pessac, France
    Bordeaux University Hospital - Haut-Lévêque
Mar 30, 2022

Multiple Myeloma Trial in Besançon, Dijon (FDG and FCH PET/CT)

Recruiting
  • Multiple Myeloma
  • FDG and FCH PET/CT
  • Besançon, France
  • +2 more
Mar 24, 2022

Fluorocholine PET/CT Trial (18F-fluorocholine PET/CT.)

Not yet recruiting
  • Fluorocholine PET/CT
  • 18F-fluorocholine PET/CT.
  • (no location specified)
Oct 24, 2022

Prostate Cancer Trial in Australia, Canada, United Kingdom (18F-FCH PET/MRI Scan)

Completed
  • Prostate Cancer
  • 18F-FCH PET/MRI Scan
  • Sydney, New South Wales, Australia
  • +9 more
Apr 4, 2022

An Imaging Study of FCH-PET-CT in Prostate Cancer andBRCA Gene

Recruiting
  • Prostate Cancer
  • +2 more
  • MRI pelvis or CT imaging
  • +2 more
  • London, Sutton, Surrey, United Kingdom
    Cancer Genetics Unit, Royal Marsden Hospital
Mar 30, 2022

Hyperparathyroidism, Parathyroid Adenoma Trial (We assessed sensitivity of 18F-FCH PET/CT in preoperative localisation of

Completed
  • Hyperparathyroidism
  • Parathyroid Adenoma
  • We assessed sensitivity of 18F-FCH PET/CT in preoperative localisation of hyperfunctioning parathyroid tissue in patients with primary hyperparathyroidism
  • (no location specified)
Sep 25, 2020

Prostate Cancer Trial in Tripler AMC (Fluourine-18 Fluoromethylcholine PET/CT Imaging)

Completed
  • Prostate Cancer
  • Fluourine-18 Fluoromethylcholine PET/CT Imaging
  • Tripler AMC, Hawaii
    Tripler Army Medical Center
Jul 19, 2022

Parathyroid Adenoma Trial (18Fluorocholine)

Not yet recruiting
  • Parathyroid Adenoma
  • (no location specified)
May 26, 2023

F18-MHF: Orthopedic Implants-Associated Infection Detection

Not yet recruiting
  • Knee Disease
  • Knee Infection
  • Atlanta, Georgia
    Emory University Hospital
May 25, 2023

Advanced Non Small Cell Lung Cancer Trial ([18F]F-AraG)

Not yet recruiting
  • Advanced Non Small Cell Lung Cancer
  • (no location specified)
Oct 24, 2023

Endometriosis Trial in Rochester (F-18 FES)

Enrolling by invitation
  • Endometriosis
  • F-18 FES
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Oct 17, 2022

NSCLC Trial in Iowa City ([18F]F-ARAG PET)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • [18F]F-ARAG PET
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Oct 10, 2023

Oncology, Prostate Cancer Trial in Edmonton ([18]F-PSMA-1007)

Not yet recruiting
  • Oncology
  • Prostate Cancer
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Jan 25, 2023

Breast Carcinoma, Fallopian Tube Carcinoma, Ovarian Carcinoma Trial in Houston (Computed Tomography, Fludeoxyglucose F-18,

Recruiting
  • Breast Carcinoma
  • +7 more
  • Computed Tomography
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 24, 2022

Amyloidosis Trial in Rochester (18-F Florbetapir PET/MR scan)

Enrolling by invitation
  • Amyloidosis
  • 18-F Florbetapir PET/MR scan
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 16, 2023

Congenital Hyperinsulinism, Insulinoma Trial in Fort Worth (Fluorodopa F 18)

Recruiting
  • Congenital Hyperinsulinism
  • Insulinoma
  • Fluorodopa F 18
  • Fort Worth, Texas
    Cook Children's Medical Center
Dec 8, 2022

Intracranial Tumor, Low Grade Glioma, Recurrent Glioblastoma Trial in San Francisco (F-18 Fluoroethyltyrosine (FET), Positron

Recruiting
  • Intracranial Neoplasm
  • +4 more
  • F-18 Fluoroethyltyrosine (FET)
  • Positron Emission Tomography (PET)
  • San Francisco, California
    University of California, San Francisco
Nov 7, 2022

Glioma Trial in Portland (Fludeoxyglucose F-18, Gadoterate Meglumine, Contrast-enhanced Magnetic Resonance Imaging)

Not yet recruiting
  • Glioma
  • Fludeoxyglucose F-18
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jun 30, 2023

An Imaging Agent With Positron Emission Tomography/Magnetic

Recruiting
  • Recurrent Soft Tissue Sarcoma
  • +2 more
  • Fluorodopa F 18
  • +4 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 4, 2023

18F-TFB PET/CT Scan in Differentiated Thyroid Cancer

Recruiting
  • Differentiated Thyroid Gland Carcinoma
  • +2 more
  • Computed Tomography
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Malignant Tumor in the Spine Trial in Houston (Computed Tomography,

Recruiting
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • Metastatic Malignant Neoplasm in the Spine
  • Computed Tomography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 13, 2022

Advanced Stage NSCLC Trial in Amsterdam ([18F]F-AraG PET scan)

Recruiting
  • Advanced Stage Non-small Cell Lung Cancer
  • [18F]F-AraG PET scan
  • Amsterdam, Netherlands
    Amsterdam UMC, location VU University Medical Center
Jan 17, 2023